Initial management of diarrhoea induced by PI3K inhibitors should include evaluation and work-up to rule out infection, followed by treatment with oral or intravenous budesonide after exclusion of infection causes (Coutre et al. 2015). This evidence concerns the gene PIK3CD and infection.